Risk factors for early infection of central venous catheters in pediatric patients

Journal of the American College of Surgeons

Volumn 186, Issue 6, 1998, Pages 654-658

  Shaul, Donald B ^a,b   Scheer, Bryan ^a   Rokhsar, Sepehr ^a   Jones, Valerie A ^a   Chan, Linda S ^a   Boody, Beth A ^a   Malogolowkin, Marcio H ^a   Mason, Wilbert H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; EQUIPMENT FAILURE; FEMALE; FEVER; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; NEUTROPENIA; REOPERATION; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 0031744620     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00096-9     Document Type: Article

References (15)

1. Parras F, Ena J, Bouza E, et al. Impact of an educational program for the prevention of colonization of intravascular catheters. Infect Control Hosp Epidemiol 1994;15:239-242.
2. Weiner ES, McGuire P, Stolar CJH, et al. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg 1992;27:155-164.
3. Archimbaud E, Guyotat D, Maupas J, et al. Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study. Eur J Cancer 1991;27:174-178.
4. Ascher DP, Shoupe BA, Maybee D, et al. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993;28:627-629.
5. Hartman GE, and Shochat SJ. Management of septic complications associated with Silastic® catheters in childhood malignancy. Pediatr Infect Dis J 1987;6:1042-1047.
6. Karmochkin M, Brunet F, Lanore JJ, et al. Recovery from staphylococcal septicaemia in neutropenic patients without removal of the previously inserted central venous catheter. Eur J Med 1993; 2:143-147.
7. Press OW, Ramsey PG, Larson EB, et al. Hickman catheter infections in patients with malignancies. Medicine 1984;63:189-200.
8. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunneled Silastic® catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993;153:1791-1796.
9. Howell PB, Walters PE, Donowitz GR, et al. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995;75:1367-1375.
10. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-1948.
11. Al-Hathal M, Malmfors G, Garwicz S, et al. Port-a-cath in children during long-term chemotherapy: complications and out-come. Pediatr Hematol Oncol 1989;6:17-22.
12. Vassilomanolakis M, Plataniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis. Bone Marrow Transplant 1995; 15:77-80.
13. Eppes SC, Troutman JL, and Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989;8:99-104.
14. Corso FA, Shaul DB, and Wolfe BM. Spinal osteomyelitis following TPN induced septicemia. J Parenter Enteral Nutr 1995;19: 291-295.
15. Rotstein C, Brock L, and Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995;16:451-458.